Literature DB >> 6326992

Comparison of actual survivorship after treatment with survivorship predicted by actual tumor-volume doubling time from tumor diameter at first observation.

T Mizuno, A Masaoka, H Ichimura, K Shibata, H Tanaka, H Niwa.   

Abstract

The predicted survival time of 56 patients with lung cancer was calculated using Geddes ' nomogram for tumor diameter and tumor doubling time. The predicted survival time correlated favorably with the actual survival time. For many patients with resection the actual survival time far exceeded the predicted survival time; thus, the latter may be very useful as a control for the evaluation of all therapies of lung cancer.

Entities:  

Mesh:

Year:  1984        PMID: 6326992     DOI: 10.1002/1097-0142(19840615)53:12<2716::aid-cncr2820531227>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Transferrin synthesis by small cell lung cancer cells acts as an autocrine regulator of cellular proliferation.

Authors:  M Vostrejs; P L Moran; P A Seligman
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

2.  The impact of histology and ground-glass opacity component on volume doubling time in primary lung cancer.

Authors:  Kai Obayashi; Kimihiro Shimizu; Seshiru Nakazawa; Toshiteru Nagashima; Toshiki Yajima; Takayuki Kosaka; Jun Atsumi; Natsuko Kawatani; Tomohiro Yazawa; Kyoichi Kaira; Akira Mogi; Hiroyuki Kuwano
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  201T1 to 67Ga uptake ratio as an indicator for predicting tumour doubling time in human pulmonary neoplasms.

Authors:  T Togawa; T Satoh; K Hoshi; K Haneda; H Yonemoto; K Kimura
Journal:  Br J Cancer       Date:  1986-04       Impact factor: 7.640

4.  Volume and Mass Doubling Time of Lung Adenocarcinoma according to WHO Histologic Classification.

Authors:  Jung Hee Hong; Samina Park; Hyungjin Kim; Jin Mo Goo; In Kyu Park; Chang Hyun Kang; Young Tae Kim; Soon Ho Yoon
Journal:  Korean J Radiol       Date:  2020-10-30       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.